tiprankstipranks
Solid Biosciences (SLDB)
NASDAQ:SLDB
US Market

Solid Biosciences (SLDB) Income Statement

452 Followers

Solid Biosciences Income Statement

Last quarter (Q3 2023), Solid Biosciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Solid Biosciences's net income was $-20.98M. See Solid Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 517.00K$ 8.09M$ 13.62M$ 0.00$ 0.00$ 0.00
Cost of Revenue
$ -969.00K$ 1.47M$ -777.00K---
Gross Profit
$ 517.00K$ 8.09M$ 13.62M---
Operating Expense
$ 47.48M$ 114.55M$ 85.87M$ 86.46M$ 119.32M$ 75.69M
Operating Income
$ -110.96M$ -106.45M$ -72.25M$ -86.46M$ -119.32M$ -75.69M
Net Non Operating Interest Income Expense
$ 25.28M$ 2.62M$ 64.00K$ 115.00K$ 1.58M$ 619.00K
Other Income Expense
$ -444.00K$ -17.86M$ -2.00K$ -1.94M$ 515.00K$ 270.00K
Pretax Income
$ -90.83M$ -85.98M$ -72.19M$ -88.29M$ -117.22M$ -74.80M
Tax Provision
--$ 0.00---
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -90.83M$ -85.98M$ -72.19M$ -88.29M$ -117.22M$ -74.80M
Basic EPS
$ -11.01$ -10.10$ 0.00$ -1.70$ -2.91$ -2.25
Diluted EPS
$ -10.79$ -10.10$ -10.20$ -1.70$ -2.91$ -2.25
Basic Average Shares
$ 67.80M$ 8.51M$ 7.12M$ 51.94M$ 40.29M$ 33.26M
Diluted Average Shares
$ 67.80M$ 8.51M$ 7.12M$ 51.94M$ 40.29M$ 33.26M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 46.52M$ 116.02M$ 85.10M$ 86.46M$ 119.32M$ 75.69M
Net Income From Continuing And Discontinued Operation
$ -90.83M$ -85.98M$ -72.19M$ -88.29M$ -117.22M$ -74.80M
Normalized Income
$ -36.09M$ -60.75M-$ -86.35M$ -117.74M$ -75.07M
Interest Expense
------
EBIT
$ -112.30M$ -85.98M$ -72.25M$ -86.46M$ -119.32M$ -75.69M
EBITDA
$ -110.93M$ -83.34M$ -68.17M$ -82.54M$ -116.49M$ -74.12M
Currency in USD

Solid Biosciences Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis